Cha Albert
- SEC CIK
- 0001397906
In the past year, 1 open-market purchase filing worth $3.00M and no sales.
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $3.00M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$3.00M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cha Albert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FLSC Frazier Life Sciences Acquisition Corp. II
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 (view filing)4:40 PM ET | Oct 15 | Same day | Cha Albert and 4 othersChief Executive Officer | PPurchaseClass A ordinary shares | +300.0K | $10.00 | +$3.00M | New position300.0K after |
KALV KalVista Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2023 (view filing) | Sep 11 | 2 days | Cha AlbertDirector | SSale | −18.0K | $10.50 | −$189.0K | −100.0%0 after |